AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...
The decision represents a setback to other local governments around the country that have sued oil companies to recoup the mounting costs of climate change. By Karen Zraick A new satellite could ...
Chiara is an award-winning investigative reporter who specialises in banking and fraud, joining Which? in 2015 following six years as a personal finance journalist at a national newspaper. Debt isn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results